Compile Data Set for Download or QSAR
Report error Found 408 Enz. Inhib. hit(s) with all data for entry = 12867
TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735202(US20250129078, Compound 220)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735199(US20250129078, Compound 217)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735198(US20250129078, Compound 216)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735181(US20250129078, Compound 199)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735180(US20250129078, Compound 198)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735176(US20250129078, Compound 194)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735182(US20250129078, Compound 200)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735226(US20250129078, Compound 244)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735237(US20250129078, Compound 255)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735236(US20250129078, Compound 254)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735234(US20250129078, Compound 252)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735231(US20250129078, Compound 249)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735219(US20250129078, Compound 237)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735218(US20250129078, Compound 236)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735217(US20250129078, Compound 235)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735216(1-(4-(8-((4-(imidazo[1,2-b]pyridazin-7-yloxy)-3-me...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735003(US20250129078, Compound 21)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735258(US20250129078, Compound 276)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735012(US20250129078, Compound 30)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735007(US20250129078, Compound 25)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735263(US20250129078, Compound 281)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735006(US20250129078, Compound 24)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM734989(US20250129078, Compound 7)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735245(US20250129078, Compound 263)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735244(US20250129078, Compound 262)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM734986(US20250129078, Compound 5)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM734983(US20250129078, Compound 4)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735239(US20250129078, Compound 257)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM734993(US20250129078, Compound 11)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM734990(US20250129078, Compound 8)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735292(US20250129078, Compound 310)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735287(US20250129078, Compound 305)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735030(US20250129078, Compound 48)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735301(US20250129078, Compound 319)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735044(US20250129078, Compound 62)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735300(US20250129078, Compound 318)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735295(US20250129078, Compound 313)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735020(US20250129078, Compound 38)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735018(US20250129078, Compound 36)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735270(US20250129078, Compound 288)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735029(US20250129078, Compound 47)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735285(US20250129078, Compound 303)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735028(US20250129078, Compound 46)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735284(US20250129078, Compound 302)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735026(US20250129078, Compound 44)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735024(US20250129078, Compound 42)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735023(US20250129078, Compound 41)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735066((R)-2-(1-acryloyl-4-(4-((3-methyl-4-((1-methyl-H-b...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735065((S)-2-(1-acryloyl-4-(4-((3-methyl-4-((1-methyl-1H-...)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2 [V777L](Homo sapiens (Human))
Cogent Biosciences

US Patent
LigandPNGBDBM735064(US20250129078, Compound 82)
Affinity DataIC50: 50nMAssay Description:In vitro enzyme assays based on CisBio HTRF-KinEASE-TK technology were used to determine compound potencies. EGFR WT (Invitrogen, cat #PR7295B) at 0....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 408 total ) | Next | Last >>
Jump to: